118753-66-5

Basic information

• Product Name: 1-TERT-BUTYLOXYCARBONYL-4-AMINO-PIPERAZINE
• Synonyms: 1-Piperazinecarboxylicacid,4-amino-,1,1-dimethylethylester(9CI);1-T-BUTYLOXYCARBONYL-4-AMINO-PIPERAZINE;tert-Butyl 4-aMinopiperazin-1-carboxylate;4-AMino-piperazine-1-carboxylic acid tert-butyl ester;1-Amino-4-(tert-butoxycarbonyl)piperazine;4-Amino-1-piperazinecarboxylic acid 1,1-dimethylethyl ester;1-PIPERAZINECARBOXYLIC ACID,4-AMINO-,1,1-DIMETHYLETHYL ESTER;1-TERT-BUTYLOXYCARBONYL-4-AMINO-PIPERAZINE
• CAS NO: 118753-66-5
• Molecular Formula: C₉H₁₉N₃O₂
• Molecular Weight: 201.27
• Product Categories: AMINOACID
• Mol File: 118753-66-5.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 281℃
• Flash Point: 124℃
• Appearance: /
• Density: 1.097
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 7.03±0.20(Predicted)
• CAS DataBase Reference: 1-TERT-BUTYLOXYCARBONYL-4-AMINO-PIPERAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-TERT-BUTYLOXYCARBONYL-4-AMINO-PIPERAZINE(118753-66-5)
• EPA Substance Registry System: 1-TERT-BUTYLOXYCARBONYL-4-AMINO-PIPERAZINE(118753-66-5)

Safety Data

• RIDADR: UN2735
• Hazardous Substances Data: 118753-66-5(Hazardous Substances Data)

Usage

General Description

1-Tert-butyloxycarbonyl-4-amino-piperazine is a chemical compound that belongs to the piperazine family and is commonly used in pharmaceutical research and drug development. It is a derivative of piperazine with a tert-butyloxycarbonyl (Boc) protecting group attached to the amino group. 1-TERT-BUTYLOXYCARBONYL-4-AMINO-PIPERAZINE has been studied for its potential use as a building block for the synthesis of various pharmaceutical compounds and as a precursor for the synthesis of bioactive molecules. The Boc protecting group enhances the stability of the amino group, making it a useful intermediate in organic synthesis. Overall, 1-tert-butyloxycarbonyl-4-amino-piperazine has potential applications in medicinal chemistry and drug discovery.

Upstream product

• 57260-71-6 1-t-Butoxycarbonylpiperazine 
• 883554-88-9 tert-butyl 4-carbamoylpiperazine-1-carboxylate 
• 877177-42-9 tert-butyl 4-nitrosopiperazine-1-carboxylate 
• 118753-70-1 N-(tert-butyloxycarbonyl)bis(2-chloroethyl)amine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 30651-60-6 piperazin-1-yl-amine 

Relevant articles and documents

Oxadiazole derivative, preparation method and applications thereof

The invention relates to an oxadiazole derivative, a preparation method and applications thereof, wherein the oxadiazole derivative has a structure represented by a formula (I), and R1, X and R2 are defined in the specification.

Solid dispersions containing an apoptosis-inducing agent

A pro-apoptotic solid dispersion comprises, in essentially non-crystalline form, a Bcl-2 family protein inhibitory compound of Formula I as defined herein, dispersed in a solid matrix that comprises (a) a pharmaceutically acceptable water-soluble polymeric carrier and (b) a pharmaceutically acceptable surfactant. A process for preparing such a solid dispersion comprises dissolving the compound, the polymeric carrier and the surfactant in a suitable solvent, and removing the solvent to provide a solid matrix comprising the polymeric carrier and the surfactant and having the compound dispersed in essentially non-crystalline form therein. The solid dispersion is suitable for oral administration to a subject in need thereof for treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer.

INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY

The present disclosure relates generally to therapeutic agents that may be useful as inhibitors of Integrated Stress Response (ISR) pathway.